Berkshire Biomedical Revenue and Competitors

Berkshire Biomedical, LLC is a privately held healthcare solutions provider focused on impacting lives by leveraging technology to improve medical outcomes. The Company's lead product under development, the Computerized Oral Prescription Administration (COPAâ„¢) System, is designed to address the intersection of two significant needs in the healthcare delivery system: virtual care delivery using technology combined with data and medication self-administration and adherence. Berkshire Biomedical's COPA system may revolutionize the standard-of-care in personalized medication delivery by pioneering the integration of biometric, cellular and database management technologies for the Intended User into a point-of-care, hand held device that can share this information with authorized health care providers as part of a disease management plan. Founded and funded by a team of experienced financial and medical technology executives, Berkshire Biomedical intends to seek broad opportunities in medical markets, drug applications, and businesses that manage the commercialization and data analytics of the device in order to maximize the COPA System's impact within the virtual care and medical technology sectors.